Medical Cannabis
Legal Medical Cannabis Means Better, Not Weaker, Health Protection
Dr. Julian Wichmann, MD, Co-Founder and CEO of Bloomwell GmbH Germany has, without question, the most progressive regulation of medical cannabis in the EU.
Bloomwell
16stories
26 Octlast updated
More in Bloomwell
- Industry Trends
Has Germany’s Medical Cannabis Market Peaked? New Laws, Surging Supply, and Industry Unrest
Over the past few years, telemedicine has reshaped how patients access medical cannabis, launching a wave of digital clinics across Europe and beyond.
- Events
International Experts Gather to Shape the Future of Cannabis Legislation at the Inaugural Global Cannabis Regulatory Summit
A comprehensive cross-section of the world’s most influential policymakers and global regulatory officials are set to meet with a group of the cannabis industry’s leading voices for an unprecedented inaugural global summit.
- Medical
Will Germany’s Medical Cannabis Boom Survive the February Election?
A month out from Germany’s federal election, alarm bells are ringing for the booming cannabis market.
- Medical
Germany’s Medical Cannabis Imports Grow 70% in Q3 as Market Explosion Continues
Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has published the medical cannabis import figures for Q3, showing that the country’s medical cannabis market is still growing rapidly.
- Data & Analysis
Most Germans Are Consuming Cannabis for Health Reasons — but Many Still Turn to Illicit Market
As reported by Cannabis Health A new survey following the landmark law change in Germany has revealed that the majority of people consuming cannabis are doing so for health issues.
- Medical
German Doctors May Remain Cautious of Prescribing Medical Cannabis Despite New Rules Opening Up Access For Millions
Last month, Germany’s Federal Joint Committee (G-BA) proposed significant changes to the medical cannabis prescription process, opening the door for medical cannabis to be prescribed via statutory health insurance (gesetzliche Krankenversicherung or GKV) This would enable around 70% of practicing German physicians to prescribe medical cannabis without prior approval from health insurance companies, which would…
- Press releases
New Report on Germany’s Medical Cannabis Market Indicates That It Is Prepared For Rapid Growth
Award-winning Frankfurt, Germany-based medical cannabis company Bloomwell Group GmbH (“Bloomwell Group”) released a report today on the state of Germany’s private, self-funded, medical cannabis flower market following the landmark implementation of the Cannabis Act (CanG) on April 1, 2024.
- Opinion
What’s in Store for the European Cannabis Industry in 2024 – Part 1
2023 was a year in which Germany, the European Union’s most populous country which has (in various forms) promised to legalise adult-use cannabis, continued to take the air out of the room and dictate much of the discourse around European cannabis.
